These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1464 related articles for article (PubMed ID: 19958938)

  • 1. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
    Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
    Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary gastric lymphoma].
    Barreda B F; Gómez P R; Quispe L D; Sánchez L J; Combe G J; Casanova M L; Celis Z J
    Rev Gastroenterol Peru; 2004; 24(3):238-62. PubMed ID: 15483686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-center study of treatment outcomes and survival in patients with primary gastric lymphomas between 1990 and 2003.
    Jezersek Novaković B; Vovk M; Juznic Setina T
    Ann Hematol; 2006 Dec; 85(12):849-56. PubMed ID: 16944146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Hodgkin's lymphomas involving the uterus: a clinicopathologic analysis of 26 cases.
    Vang R; Medeiros LJ; Ha CS; Deavers M
    Mod Pathol; 2000 Jan; 13(1):19-28. PubMed ID: 10658906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary malignant lymphoma of thyroid gland:clinical analysis of 28 cases].
    Zhao WC; Dai JJ
    Ai Zheng; 2003 Nov; 22(11):1224-7. PubMed ID: 14613658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.
    Al-Tourah AJ; Gill KK; Chhanabhai M; Hoskins PJ; Klasa RJ; Savage KJ; Sehn LH; Shenkier TN; Gascoyne RD; Connors JM
    J Clin Oncol; 2008 Nov; 26(32):5165-9. PubMed ID: 18838711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24553 patients with Hashimoto's disease.
    Watanabe N; Noh JY; Narimatsu H; Takeuchi K; Yamaguchi T; Kameyama K; Kobayashi K; Kami M; Kubo A; Kunii Y; Shimizu T; Mukasa K; Otsuka F; Miyara A; Minagawa A; Ito K; Ito K
    Br J Haematol; 2011 Apr; 153(2):236-43. PubMed ID: 21371004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
    J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma.
    Al-Mansour M; Connors JM; Gascoyne RD; Skinnider B; Savage KJ
    J Clin Oncol; 2010 Feb; 28(5):793-9. PubMed ID: 20048177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases.
    Roman S; Lin R; Sosa JA
    Cancer; 2006 Nov; 107(9):2134-42. PubMed ID: 17019736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of non-Hodgkin's lymphomas of 210 patients with nodular and favorable histologies--report of the Japanese Lymphoma Radiation Therapy Study Group].
    Hayabuchi N; Jinguu K; Masaki N; Horiuchi J; Niibe H; Morita K; Watanabe S; Kaneta K
    Gan No Rinsho; 1988 Apr; 34(5):589-98. PubMed ID: 3290531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for pleural lymphoma patients.
    Aozasa K; Ohsawa M; Iuchi K; Mori T; Komatsu H; Tajima K; Minato K; Tajima K; Shimoyama M
    Jpn J Clin Oncol; 1991 Dec; 21(6):417-21. PubMed ID: 1805046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of oral and paraoral malignant lymphoma: a population-based review of 361 cases.
    Epstein JB; Epstein JD; Le ND; Gorsky M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Nov; 92(5):519-25. PubMed ID: 11709688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factor analysis of 116 cases of primary gastrointestinal non-Hodgkin's lymphoma].
    Lin XG; Huang KH; Xie DR; Liu TH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):243-5. PubMed ID: 18250053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ophthalmologic and intraocular non-Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factors.
    Meunier J; Lumbroso-Le Rouic L; Vincent-Salomon A; Dendale R; Asselain B; Arnaud P; Fourquet A; Desjardins L; Plancher C; Validire P; Chaoui D; Lévy C; Decaudin D
    Hematol Oncol; 2004 Dec; 22(4):143-58. PubMed ID: 16134191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathologic features of primary thyroid lymphoma].
    Zhou SY; Huang DZ; Shi YK; He XH; Wu YH; Li YX
    Ai Zheng; 2005 Jan; 24(1):95-8. PubMed ID: 15642210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
    Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
    Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Hodgkin lymphoma of the breast.
    Ganjoo K; Advani R; Mariappan MR; McMillan A; Horning S
    Cancer; 2007 Jul; 110(1):25-30. PubMed ID: 17541937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma.
    Eser B; Sari I; Canoz O; Altuntas F; Cakmak E; Ozturk A; Ozkan M; Er O; Cetin M; Unal A
    Am J Hematol; 2006 May; 81(5):307-14. PubMed ID: 16628716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.
    Gundrum JD; Mathiason MA; Moore DB; Go RS
    J Clin Oncol; 2009 Nov; 27(31):5227-32. PubMed ID: 19770371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.